Medipal Holdings Corporation (MEPDF)
OTHER OTC:MEPDF
MEPDF Stock Chart & Stats
$16.50
$0.00(0.00%)
At close: 4:00 PM EDT
$16.50
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$14.80 - $20.65
Previous CloseN/A
Volume100.00
Average Volume (3M)0.00
Market Cap
$3.30B
Enterprise Value$358.78B
Total Cash (Recent Filing)$246.03B
Total Debt (Recent Filing)$38.85B
Price to Earnings (P/E)9.3
Beta0.34
Next Earnings
May 19, 2026EPS Estimate
0.24Next Dividend Ex-DateN/A
Dividend Yield2.6%
Share Statistics
EPS (TTM)0.47
Shares Outstanding215,975,040
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-8.97
Price to Book (P/B)0.79
Price to Sales (P/S)0.13
P/FCF Ratio9.42
Enterprise Value/Market Cap108.84
Enterprise Value/Revenue0.10
Enterprise Value/Gross Profit1.47
Enterprise Value/Ebitda4.79
Forecast
1Y Price Target
$16.96Price Target Upside2.78% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)1.11
Revenue Forecast (FY)$24.16B
Bulls Say, Bears Say
Bulls Say
Robust Balance SheetExtremely low leverage and a strong equity ratio materially reduce financial risk and increase resilience to demand shocks or reimbursement changes. This durable capital structure supports sustained investment in logistics, stable dividend policy, and optionality for M&A or capex without relying on debt.
Stable Revenue Growth From WholesalingConsistent mid-single-digit revenue growth reflects the enduring role as a national pharmaceuticals and medical supplies distributor. The core wholesale model benefits from recurring demand, large-volume purchasing and logistics scale that support predictable top-line expansion over multiple quarters.
Solid Free Cash Flow GenerationHigh free cash flow relative to net income indicates the business generates usable cash to fund capex, working capital and dividends. Over time strong FCF supports financial flexibility, reduces dependence on external financing and enables reinvestment into distribution and logistics capabilities.
Bears Say
Thin Profitability MarginsLow gross and net margins reflect the competitive, low-margin nature of pharmaceutical wholesale. Persistent thin margins limit the firm's ability to absorb cost inflation or fund margin-expanding initiatives, making long-term profit improvement dependent on operational efficiencies or higher-margin services.
Weak Cash Conversion And VolatilityVery low operating cash conversion and volatile free cash flow growth signal earnings may not consistently translate into operating liquidity. Over months this can constrain working capital management and discretionary spending, increasing sensitivity to inventory swings and payment timing in the supply chain.
Declining EPS GrowthNegative EPS growth suggests earnings are under pressure despite revenue growth, implying margin compression, one-offs, or higher costs. Persistent EPS declines can erode shareholder returns and limit retained earnings for reinvestment, making long-term profitability recovery harder without structural changes.
Medipal Holdings News
MEPDF FAQ
What was Medipal Holdings Corporation’s price range in the past 12 months?
Medipal Holdings Corporation lowest stock price was $14.80 and its highest was $20.65 in the past 12 months.
What is Medipal Holdings Corporation’s market cap?
Medipal Holdings Corporation’s market cap is $3.30B.
When is Medipal Holdings Corporation’s upcoming earnings report date?
Medipal Holdings Corporation’s upcoming earnings report date is May 19, 2026 which is in 35 days.
How were Medipal Holdings Corporation’s earnings last quarter?
Medipal Holdings Corporation released its earnings results on Feb 09, 2026. The company reported $0.469 earnings per share for the quarter, beating the consensus estimate of $0.316 by $0.153.
Is Medipal Holdings Corporation overvalued?
According to Wall Street analysts Medipal Holdings Corporation’s price is currently Undervalued.
Does Medipal Holdings Corporation pay dividends?
Medipal Holdings Corporation pays a Semiannually dividend of $0.217 which represents an annual dividend yield of 2.6%. See more information on Medipal Holdings Corporation dividends here
What is Medipal Holdings Corporation’s EPS estimate?
Medipal Holdings Corporation’s EPS estimate is 0.24.
How many shares outstanding does Medipal Holdings Corporation have?
Medipal Holdings Corporation has 215,975,040 shares outstanding.
What happened to Medipal Holdings Corporation’s price movement after its last earnings report?
Medipal Holdings Corporation reported an EPS of $0.469 in its last earnings report, beating expectations of $0.316. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Medipal Holdings Corporation?
Currently, no hedge funds are holding shares in MEPDF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Medipal Holdings Corporation
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products. In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; health insurance claims reviews, medical coding dispatch, outsourcing, and remote education activities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; and planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand. Medipal Holdings Corporation serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. Medipal Holdings Corporation was founded in 1898 and is headquartered in Tokyo, Japan.
MEPDF Stock 12 Month Forecast
Average Price Target
$16.96
▲(2.78% Upside)
Technical Analysis
Alfresa Holdings
―
Sundrug Co
―
Sugi Holdings Co
―
Suzuken Co
―
KUSURI NO AOKI HOLDINGS CO.,LTD.
―
Ownership Overview
―
Insiders
6.26% Mutual Funds
― Other Institutional Investors
87.36% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---